{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:55:15Z","timestamp":1791190515971,"version":"4.1.0"},"reference-count":35,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:00:00Z","timestamp":1791158400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Public Health"],"abstract":"<jats:p>Diabetic retinopathy (DR) remains a preventable cause of vision loss as diabetes prevalence rises worldwide. Artificial intelligence (AI)-enabled retinal screening has progressed from retrospective validation to prospective and real-world deployment, with recent reviews showing high diagnostic performance across fundus photography, smartphone-based systems, and autonomous platforms. Yet diagnostic accuracy alone does not ensure public health benefit. Population impact can be lost when eligible people are not reached, images are ungradable, results are delayed, referrals are incomplete, treatment capacity is insufficient, or disadvantaged groups face financial, geographic, or digital barriers. Unlike reviews centered mainly on diagnostic accuracy or economic performance, this Mini Review reframes AI-enabled DR screening as a population-health intervention spanning detection through completion of effective eye care. We synthesize evidence on diagnostic validity, implementation, economics, referral completion, care cascades, patient-centered outcomes, equity, and governance. We argue that effectiveness and cost-effectiveness are properties of the complete screening-to-treatment pathway, not the algorithm alone, and propose a four-domain framework encompassing technical validity, service integration, population impact, and equity and sustainability. Future research should prioritize comparative implementation studies and outcome sets that capture screening reach, gradability, referral completion, treatment initiation, time to treatment, avoidable vision loss, vision-related quality of life, acceptability, costs, and subgroup equity. The policy question is no longer whether AI can detect DR, but whether health systems can translate automated detection into equitable completion of effective eye care at scale.<\/jats:p>","DOI":"10.3389\/fpubh.2026.1976572","type":"journal-article","created":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:38:21Z","timestamp":1791189501000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["From validation to public health impact: implementing equitable AI-enabled diabetic retinopathy screening"],"prefix":"10.3389","volume":"14","author":[{"given":"Jing","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, People's Hospital of Leshan, Leshan","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Ophthalmology, People's Hospital of Leshan, Leshan","place":["Sichuan, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,5]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1111\/ceo.12696","article-title":"Diabetic retinopathy: global prevalence, major risk factors, screening practices and public health challenges: a review","volume":"44","author":"Ting","year":"2016","journal-title":"Clin Exp Ophthalmol."},{"key":"B2","article-title":"IDF","author":"International","year":"2025"},{"key":"B3","doi-asserted-by":"publisher","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1608","DOI":"10.1016\/j.ophtha.2018.04.007","article-title":"Guidelines on diabetic eye care: the International Council of Ophthalmology recommendations for screening, follow-up, referral, and treatment based on resource settings","volume":"125","author":"Wong","year":"2018","journal-title":"Ophthalmology."},{"key":"B5","article-title":"WHO","year":"2019"},{"key":"B6","doi-asserted-by":"publisher","first-page":"2402","DOI":"10.1001\/jama.2016.17216","article-title":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs","volume":"316","author":"Gulshan","year":"2016","journal-title":"JAMA."},{"key":"B7","doi-asserted-by":"publisher","first-page":"2211","DOI":"10.1001\/jama.2017.18152","article-title":"Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes","volume":"318","author":"Ting","year":"2017","journal-title":"JAMA."},{"key":"B8","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1038\/s41746-018-0040-6","article-title":"Pivotal trial of an autonomous AI-based diagnostic system for detection of diabetic retinopathy in primary care offices","volume":"1","author":"Abr\u00e0moff","year":"2018","journal-title":"NPJ Digit Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"e35","DOI":"10.1016\/S2589-7500(19)30004-4","article-title":"Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study","volume":"1","author":"Bellemo","year":"2019","journal-title":"Lancet Digit Health."},{"key":"B10","doi-asserted-by":"publisher","first-page":"1168","DOI":"10.2337\/dc20-1877","article-title":"Multicenter, head-to-head, real-world validation study of seven automated artificial intelligence diabetic retinopathy screening systems","volume":"44","author":"Lee","year":"2021","journal-title":"Diabetes Care."},{"key":"B11","doi-asserted-by":"publisher","first-page":"e235","DOI":"10.1016\/S2589-7500(22)00017-6","article-title":"Real-time diabetic retinopathy screening by deep learning in a multisite national screening programme: a prospective interventional cohort study","volume":"4","author":"Ruamviboonsuk","year":"2022","journal-title":"Lancet Digit Health."},{"key":"B12","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.ajo.2024.02.012","article-title":"Diagnostic accuracy of artificial intelligence-based automated diabetic retinopathy screening in real-world settings: a systematic review and meta-analysis","volume":"263","author":"Joseph","year":"2024","journal-title":"Am J Ophthalmol."},{"key":"B13","doi-asserted-by":"publisher","first-page":"110943","DOI":"10.1016\/j.diabres.2023.110943","article-title":"Diagnostic accuracy of smartphone-based artificial intelligence systems for detecting diabetic retinopathy: a systematic review and meta-analysis","volume":"205","author":"Hasan","year":"2023","journal-title":"Diabetes Res Clin Pract."},{"key":"B14","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1016\/j.ajo.2025.02.022","article-title":"Diagnostic accuracy of IDx-DR for detecting diabetic retinopathy: a systematic review and meta-analysis","volume":"273","author":"Khan","year":"2025","journal-title":"Am J Ophthalmol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"510","DOI":"10.2337\/dc25-1493","article-title":"Real-world prospective validation and economic evaluation of deep learning-based diabetic retinopathy detection from fundus photographs: a systematic review and meta-analysis","volume":"49","author":"Ran","year":"2026","journal-title":"Diabetes Care."},{"key":"B16","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s41073-019-0064-8","article-title":"SANRA\u2014a scale for the quality assessment of narrative review articles","volume":"4","author":"Baethge","year":"2019","journal-title":"Res Integr Peer Rev."},{"key":"B17","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1007\/s40123-024-01086-8","article-title":"Transforming non-digital, clinical workflows to detect and track vision-threatening diabetic retinopathy via a digital platform integrating artificial intelligence: implementation research","volume":"14","author":"Chotcomwongse","year":"2025","journal-title":"Ophthalmol Ther."},{"key":"B18","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.xops.2022.100168","article-title":"Impact of artificial intelligence assessment of diabetic retinopathy on referral service uptake in a low-resource setting: the RAIDERS randomized trial","volume":"2","author":"Mathenge","year":"2022","journal-title":"Ophthalmol Sci."},{"key":"B19","doi-asserted-by":"publisher","first-page":"e001154","DOI":"10.1136\/bmjdrc-2019-001154","article-title":"Adherence to ophthalmology referral, treatment and follow-up after diabetic retinopathy screening in the primary care setting","volume":"8","author":"Bresnick","year":"2020","journal-title":"BMJ Open Diabetes Res Care."},{"key":"B20","doi-asserted-by":"publisher","first-page":"3323","DOI":"10.2147\/OPTH.S422513","article-title":"Artificial intelligence improves patient follow-up in a diabetic retinopathy screening program","volume":"17","author":"Dow","year":"2023","journal-title":"Clin Ophthalmol."},{"key":"B21","doi-asserted-by":"publisher","first-page":"421","DOI":"10.1038\/s41467-023-44676-z","article-title":"Autonomous artificial intelligence increases screening and follow-up for diabetic retinopathy in youth: the ACCESS randomized control trial","volume":"15","author":"Wolf","year":"2024","journal-title":"Nat Commun."},{"key":"B22","doi-asserted-by":"publisher","first-page":"468","DOI":"10.1038\/s41746-026-02616-3","article-title":"Referral uptake after diabetic retinopathy screening with artificial intelligence-assisted care pathways: a systematic review and meta-analysis","volume":"9","author":"Leigh","year":"2026","journal-title":"NPJ Digit Med."},{"key":"B23","doi-asserted-by":"publisher","first-page":"e117683","DOI":"10.1136\/bmjopen-2026-117683","article-title":"Diabetic retinopathy treatment cascade and care continuum in the USA: a systematic review","volume":"16","author":"Fu","year":"2026","journal-title":"BMJ Open."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e41624","DOI":"10.2196\/41624","article-title":"Artificial intelligence in community-based diabetic retinopathy telemedicine screening in urban China: cost-effectiveness and cost-utility analyses with real-world data","volume":"9","author":"Lin","year":"2023","journal-title":"JMIR Public Health Surveill."},{"key":"B25","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1038\/s41746-024-01032-9","article-title":"Economic evaluation for medical artificial intelligence: accuracy vs. cost-effectiveness in a diabetic retinopathy screening case","volume":"7","author":"Wang","year":"2024","journal-title":"NPJ Digit Med."},{"key":"B26","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/ceo.70016","article-title":"Health economic considerations for the implementation of artificial intelligence-enabled diabetic retinopathy screening: a review","volume":"54","author":"Leigh","year":"2026","journal-title":"Clin Exp Ophthalmol."},{"key":"B27","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1001\/jamaophthalmol.2023.6435","article-title":"Diabetic retinopathy and quality of life: a systematic review and meta-analysis","volume":"142","author":"Zayed","year":"2024","journal-title":"JAMA Ophthalmol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/bjo-2022-322683","article-title":"Feasibility and acceptance of artificial intelligence-based diabetic retinopathy screening in Rwanda","volume":"108","author":"Whitestone","year":"2024","journal-title":"Br J Ophthalmol."},{"key":"B29","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1080\/09286586.2024.2434738","article-title":"Feasibility and patient experience of a pilot artificial intelligence-based diabetic retinopathy screening program in Northern Ontario","volume":"32","author":"Bhambhwani","year":"2025","journal-title":"Ophthalmic Epidemiol."},{"key":"B30","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/s41746-026-02460-5","article-title":"Autonomous AI-assisted diabetic retinopathy screening at primary care is associated with increased presentation to eye care by at risk patients","volume":"9","author":"Leong","year":"2026","journal-title":"NPJ Digit Med."},{"key":"B31","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1038\/s41746-023-00913-9","article-title":"Considerations for addressing bias in artificial intelligence for health equity","volume":"6","author":"Abr\u00e0moff","year":"2023","journal-title":"NPJ Digit Med."},{"key":"B32","doi-asserted-by":"publisher","first-page":"5779276","DOI":"10.1155\/2022\/5779276","article-title":"Cross-camera external validation for artificial intelligence software in diagnosis of diabetic retinopathy","volume":"2022","author":"Tsai","year":"2022","journal-title":"J Diabetes Res."},{"key":"B33","doi-asserted-by":"publisher","first-page":"4349","DOI":"10.1038\/s41598-026-36970-9","article-title":"Real-world performance of the AI diagnostic system IDx-DR in the diagnosis of diabetic retinopathy and its main confounders","volume":"16","author":"Hunfeld","year":"2026","journal-title":"Sci Rep."},{"key":"B34","unstructured":"Geneva\n          World Health Organization\n          Regulatory Considerations On Artificial Intelligence For Health\n          \n          2023"},{"key":"B35","unstructured":"Marketing Submission Recommendations For A Predetermined Change Control Plan For Artificial Intelligence-Enabled Device Software Functions: Guidance For Industry And Food And Drug Administration Staff\n          \n          2025"}],"container-title":["Frontiers in Public Health"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1976572\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T08:38:22Z","timestamp":1791189502000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fpubh.2026.1976572\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,5]]},"references-count":35,"alternative-id":["10.3389\/fpubh.2026.1976572"],"URL":"https:\/\/doi.org\/10.3389\/fpubh.2026.1976572","relation":{},"ISSN":["2296-2565"],"issn-type":[{"value":"2296-2565","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,5]]},"article-number":"1976572"}}